Funding Rounds
AgomAb Therapeutics

AgomAb Therapeutics Series B (2021, $74M)

AgomAb Therapeutics

Drug discovery platform for fibrotic diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $74.00M

Raised Date: 2021-10-01

Investors